Cytek Biosciences, Inc. CTKB Product — Total revenue, net
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s product — total revenue, net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s product — total revenue, net?
- Cytek Biosciences, Inc. (CTKB) reported product — total revenue, net of $28.78M in Q1 2026.
- How has Cytek Biosciences, Inc.'s product — total revenue, net changed year-over-year?
- Cytek Biosciences, Inc.'s product — total revenue, net increased by 2.4% year-over-year, from $28.11M to $28.78M.
- What is the long-term trend for Cytek Biosciences, Inc.'s product — total revenue, net?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s product — total revenue, net has grown at a 4.8% compound annual growth rate (CAGR), from $119.52M to $144.23M.
- What does product — total revenue, net mean?
- This metric represents the total net revenue generated specifically from the sale of physical instruments, reagents, and associated hardware products after accounting for returns, allowances, and discounts. It serves as a primary indicator of market demand for the company's core technology platforms and hardware-based solutions. Tracking this figure helps investors assess the commercial adoption and sales performance of the company's specialized equipment portfolio.